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Abstract
In the present study we examined the association between baseline alcohol consumption and 10-year mortality in
subjects with normal and abnormal glucose levels (diabetes, impaired fasting glucose (IFG) or impaired glucose
tolerance (IGT)). Furthermore, we assessed the 6-year cumulative incidence of diabetes in categories of alcohol
consumption. In the Hoorn Study, which started in 1989, alcohol intake was assessed by questionnaire in 2393
subjects who were subsequently categorised into four groups of alcohol consumption (non-drinkers, up to 10 g per
day, 10–30 and 30 g per day). Glucose tolerance status by oral glucose tolerance test was classified according to
the WHO-1999 diagnostic criteria. Subjects who drank up to 10 g per day of alcohol had the lowest mortality risk.
The age- and sex-adjusted mortality risks for non-drinkers were 1.55 (1.04–2.32) for subjects with normal glucose
levels and 1.72 (1.05–2.82) for subjects with abnormal glucose levels. The risk of diabetes was also lowest for subjects
who consumed up to 10 g per day: 8.0 versus 12.9% for non-drinkers (P0.05). Higher alcohol intakes were
associated with increasing risks for mortality and diabetes. Adjustment for classical cardiovascular risk factors and
other lifestyle variables did not materially affect the estimates. In conclusion, moderate alcohol consumption was
associated with a lower risk for mortality and diabetes. © 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Numerous studies have demonstrated a J-
shaped relationship between alcohol consumption
and mortality in the general population, with the
lowest risks for mortality observed with light to
moderate alcohol consumption [1–4]. Possible
mechanisms for this protective effect of moderate
alcohol consumption include beneficial effects on
high-density lipoprotein, platelet aggregation and
fibrinolytic activity [5–7].
Subjects with diabetes or elevated fasting or
postload glucose have an increased risk for all-
cause mortality compared with subjects with nor-
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mal glucose levels [8,9]. As in the Nurses’ Health
Study the beneficial effect of moderate alcohol
consumption was highest in those with an in-
creased risk of cardiovascular disease [10], it
might be expected that diabetic subjects profit
more from moderate alcohol consumption than
the general population. As far as we know, only
three prospective cohort studies have been per-
formed among diabetic subjects until now [11–
13]. These studies showed an inverse association
between alcohol consumption and coronary heart
disease (CHD) mortality, but did not report on
the risks associated with higher alcohol
consumption.
As moderate alcohol consumption also benefi-
cially affects insulin sensitivity and glucose
metabolism [14,15], several studies have been per-
formed to study the effect of alcohol consumption
on the incidence of diabetes. In some of these
studies the association was J-shaped, with the
lowest incidence of diabetes in subjects with mod-
erate alcohol consumption [16,17], while others
observed an overall positive [18] or an inverse
association [19,20]. However, because of differ-
ences in the diagnosis of diabetes and the range of
alcohol intake, it is difficult to compare these
studies directly.
In the present study, we investigated the associ-
ation between alcohol consumption and all-cause
mortality in subjects with normal and abnormal
glucose levels at baseline. Furthermore, in the
same population we assessed the risk of diabetes
associated with alcohol consumption.
2. Materials and methods
2.1. Study population; baseline and follow-up
measurements
The Hoorn Study is a population-based cohort
study on glucose intolerance in a general Dutch
elderly population [21]. In 1989, a random sample
of all inhabitants of Hoorn aged 50–75 were
invited to participate in the study. Of the eligible
subjects, 71.5% agreed to participate, resulting in
the Hoorn Study cohort of 2484 participants. In
the present study, analyses concerning mortality
have been performed in 2393 subjects, because of
missing values for glucose levels or alcohol con-
sumption. The population register of the city of
Hoorn provided information on vital status.
Between January 1996 and December 1998, the
majority (n=2086) of the initial cohort was in-
vited to participate in follow-up measurements.
Of the original cohort, 108 subjects had moved
out of Hoorn, 150 subjects had died before 1996
and 140 subjects were not invited for logistic
reasons. A total of 1513 subjects (72.5%) partici-
pated. In the present study the analyses concern-
ing the cumulative incidence of diabetes have been
done in 1322 participants of the follow-up mea-
surements who did not have diabetes or missing
information on alcohol intake at baseline.
The Ethics Committee of the Vrije Universiteit
Medical Centre Amsterdam approved the Hoorn
Study and written informed consent was obtained
from all participants.
2.2. Glucose measurements
Both at baseline and at follow-up fasting glu-
cose and glucose 2 h after a 75 g oral glucose load
were determined by a glucose dehydrogenase
method (Merck, Darmstad, Germany). Subjects
were classified according to the criteria of the
WHO Consultation of 1999 [22]. Diabetes was
diagnosed if fasting plasma glucose was 7.0
mmol/l or postload glucose 11.1 mmol/l. Sub-
jects already treated for diabetes by a general
practitioner or clinician (either glucose lowering
medication or a diet) were also categorised as
diabetic subjects. A fasting plasma glucose be-
tween 6.1 and 7.0 mmol/l is defined as impaired
fasting glucose (IFG), while a postload glucose
level between 7.8 and 11.1 mmol/l is defined as
impaired glucose tolerance (IGT) [22]. Abnormal
glucose levels were defined as either diabetes, IFG
or IGT.
2.3. Alcohol consumption
Information about nutritional habits was ob-
tained by a validated semi-quantitative food fre-
quency questionnaire, including questions about
alcohol consumption [23]. Subjects were asked
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whether they drank alcohol and if so, how many
glasses of various types of alcoholic beverages
they consumed a week. This information was
converted using a computerised version of the
Dutch Food Composition Table [24]. Subjects
were categorised in four groups of alcohol con-
sumption: non-drinkers, up to 10 g per day, 10–
30 g per day and more than 30 g per day. In the
analyses concerning the cumulative incidence of
diabetes, the two highest categories of alcohol
consumption were taken as one category (10 g
per day), because of small numbers.
2.4. Other measurements
Sitting blood pressure was measured twice on
the right arm with a random-zero sphygmo-
manometer (Hawksley–Gelman, Lancing, UK).
The average was used for analyses. Subjects were
considered hypertensive if systolic blood pressure
was 160 mmHg, diastolic blood pressure 95
mmHg, or when using anti-hypertensive medica-
tion [25]. Weight and height were measured with
subjects wearing light clothes only, and the body
mass index (BMI) was calculated as weight/height
squared (kg/m2). Waist and hip circumferences
were measured according to a standardised proce-
dure [26], and the waist-to-hip ratio (WH-ratio)
was defined as waist circumference divided by hip
circumference. Fasting specific insulin level was
quantified with an insulin-specific double-anti-
body radio-immunoassay (antibody SP21; Linco,
St. Louis, MO). Triglycerides, total cholesterol
and high-density lipoprotein cholesterol (HDL-C)
were determined from fasting blood samples by
enzymatic techniques (Boehringer Mannheim,
Mannheim, Germany). Information on smoking
habits and physical activity was obtained by ques-
tionnaire. Information on prevalent cardiovascu-
lar diseases was obtained using a translated
version of the Rose questionnaire from the Lon-
don School of Hygiene [27].
2.5. Statistical analyses
Differences in baseline characteristics in cate-
gories of alcohol consumption were tested by
analysis of covariance in case the variables were
continuous and normally distributed (adjusted for
age and sex). Differences in proportions were
tested with logistic regression. Fasting specific in-
sulin and triglycerides were log-transformed be-
fore testing, because of the skewed distribution of
these variables.
Mortality was expressed as the number of sub-
jects who died per 1000 person years of follow-up.
Age- and sex-adjusted relative risks (RRs) (hazard
ratios) and 95%-confidence intervals (CI) were
estimated using Cox’ proportional hazards model.
In a second model we adjusted additionally for
confounding factors: cigarette smoking (yes or
no), participation in sport activities, prevalent car-
diovascular disease and hypertension. Subse-
quently, we also included HDL-C, insulin,
triglycerides and WH-ratio as possible intermedi-
ate variables in the causal chain linking alcohol to
mortality. The reference category was the cate-
gory of moderate drinkers (up to 10 g per day).
All regression models were stratified for normal
and abnormal glucose levels.
The cumulative incidence of diabetes was calcu-
lated as the proportion of subjects who had devel-
oped diabetes at the follow-up measurements.
Logistic regression was used to calculate odds
ratios (OR). The same possible confounding and
intermediate variables in the models for mortality
were used. All P values were based on two-sided
tests, and the cut-off for statistical significance
was 0.05.
3. Results
A total of 1637 subjects (68.4%) reported regu-
lar alcohol consumption, varying from 0.7 up to
98.0 g per day (mean 13.0 g per day). For men the
mean alcohol consumption was 15.6 g per day,
for women 9.7 g per day.
The category of 756 subjects who did not drink
alcohol mainly consisted of women (75%). Com-
pared with the subjects who reported moderate
alcohol consumption (10 g per day), these sub-
jects were more often hypertensive and less often
smokers, were less physically active, had a lower
HDL-C level, and a lower WH-ratio. Subjects in
the category of 30 g alcohol per day were most
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Table 1
Baseline characteristics by categories of alcohol consumption (g per day)
10Alcohol category 10–300 30
0Alcohol intake (mean) 4.8 17.6 41.9
936 519756 182N
63.47.2Age (years) 61.27.3a 60.37.1a 59.76.6a
45.5a 65.9aSex (% men) 74.2a25.0
7.5a 10.013.4 11.5Prevalent diabetes (%)
77.3 (60.3–100.9) 74.5 (59.3–95.8)aFasting specific insulin (pmol/l) 76.4 (59.0–96.4)78.6 (62.6–105.2)
0.890.09 0.910.080.880.08 0.940.09aWH-ratio
27.04.0BMI (kg/m2) 26.33.4a 26.23.3 26.73.0
6.631.13 6.581.126.741.28 6.721.07aChol. (mmol/l)
1.290.34HDL-C (mmol/l) 1.340.37a 1.320.37a 1.400.41a
1.30 (1.00–1.80)a 1.40 (1.10–2.00)Triglycerides (mmol/l) 1.50 (1.10–2.30)1.40 (1.00–2.00)
28.5a 26.6a39.7 33.5Hypertension (%)
17.9a 13.9aPrevalent CVD (%) 20.922.1
29.5 39.8a23.5 49.5aSmoking (%)
Sport (%) 19.7 30.7a 33.1a 29.1a
WH-ratio, waist to hip ratio; BMI, body mass index; Chol, cholesterol; HDL-C, high density lipoprotein cholesterol; CVD,
cardiovascular disease; sport, active in sport activities; Data are presented as meansSD, median (25–75th percentile), or
proportion. Triglycerides and fasting specific insulin are tested with log-transformed data. All differences were tested adjusted for
age and sex, and the level of significance was 0.05.
a Significantly different from non-drinkers, adjusted for age and sex.
often men (74.2%), had a higher WH-ratio (0.94),
were more likely to smoke often (49.5%) and had
a mean HDL-C level of 1.40 mmol/l (Table 1).
During the follow-up until January 1999 (mean
7.6, range 0.1–9.2 years), 268 subjects died
(11.2%).
The association between alcohol consumption
and mortality did not clearly differ between sub-
jects with normal glucose levels and subjects with
abnormal glucose levels. As shown in Fig. 1,
subjects who consumed moderate amounts of al-
cohol (up to 10 g per day) had the lowest mortal-
ity rate. Due to the high absolute mortality risk of
subjects with abnormal glucose levels, the risk
difference between moderate alcohol consumption
and non-drinking was higher (9.2 per 1000 person
years) than in subjects with normal glucose levels
(5.7 per 1000 person years).
In subjects with normal glucose levels the age-
and sex-adjusted relative risk for all-cause mortal-
ity relative to the category of 10 g per day was
1.55 (1.04–2.32) for non-drinkers and 1.05 (0.64–
1.72) and 2.10 (1.15–3.85) for those consuming
10–30 g per day, and 30 g per day, respec-
tively. In subjects with abnormal glucose levels
these RRs were 1.72 (1.05–2.82), 1.44 (0.84–2.47)
and 2.08 (1.10–3.96), respectively. In these sub-
jects, alcohol intakes higher than 10 g per day
were thus associated with a steeper increase in
mortality risk (Table 2). Additional adjustment
for cardiovascular risk factors and other lifestyle
variables slightly reduced the estimates (Table 2).
Of the 1322 subjects who did not have diabetes
at baseline and who participated in the follow-up
measurements, 131 (9.9%) had diabetes at the
follow-up measurements. Fig. 2 shows the cumu-
lative incidence of diabetes in categories of alco-
hol consumption. Subjects who consumed up to
Fig. 1. All-cause mortality for categories of alcohol consump-
tion stratified for subjects with normal and abnormal glucose
levels.
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Table 2
RR of all-cause mortality for categories of alcohol consumption, in subjects with normal and abnormal glucose levels
10 10–30Alcohol (g per day) 300
936 519 182756N
Normal glucose leels
N 512 730 372 120
1.55 (1.04–2.32)Model 1 1 1.05 (0.64–1.72) 2.10 (1.15–3.85)
1 1.02 (0.62–1.67)1.35 (0.90–2.03) 1.80 (0.98–3.31)Model 2
1.38 (0.91–2.08)Model 3 1 1.02 (0.62–1.67) 1.63 (0.87–3.07)
Abnormal glucose leels (diabetes, IFG or IGT)
206 147244 62N
1.72 (1.05–2.82)Model 1 1 1.44 (0.84–2.47) 2.08 (1.10–3.96)
1Model 2 1.52 (0.88–2.61)1.62 (0.98–2.66) 1.87 (0.98–3.58)
1 1.56 (0.90–2.69)1.61 (0.98–2.65) 1.69 (0.86–3.32)Model 3
Model 1, adjusted for age and sex; Model 2, additionally adjusted for smoking, sport, prevalent CVD and hypertension; Model 3,
additionally (with respect to model 2) adjusted for HDL-C, fasting specific insulin, triglycerides and WH-ratio.
10 g of alcohol a day had the lowest cumulative
incidence: 8.0 versus 12.9% for non-drinkers (P
0.05) and 9.8% for subjects who had a higher
alcohol intake.
Subjects who consumed no alcohol at all had
the highest risk for progression to diabetes. Rela-
tive to the category who consumed up to 10 g per
day, the age- and sex-adjusted risk was 1.56
(0.99–2.48). The risk for subjects who consumed
larger amounts of alcohol was 1.29 (0.80–2.06).
Adjustment for possible confounders did not
changed the estimates (data not shown).
4. Discussion
In the population of the Hoorn Study, moder-
ate alcohol consumption (up to 10 g per day) was
associated with the lowest risk for mortality and
diabetes compared to non-drinking or a higher
alcohol consumption. The absolute risk reduction
for mortality was greater for subjects with abnor-
mal glucose levels, but the increase in risks was
steeper with increasing amounts of alcohol intake.
Information about alcohol consumption was
obtained by a semi-quantitative food frequency
questionnaire [23]. This method is liable to under-
reporting and inaccuracy [28,29]. However, the
questionnaire we used was validated by compari-
son with a modified dietary history, and the Pear-
son correlation coefficient for alcohol consump-
tion was 0.77 [23]. As the food frequency ques-
tionnaire contained many questions about nutri-
tion habits with only a few of them about
alcoholic drinks, it is less likely that selection bias
occurred due to heavy drinkers not returning their
questionnaires. In a large study in Germany, bio-
logical markers of alcohol consumption showed
no evidence for underreporting of self-reported
alcohol consumption [30]. As we divided alcohol
consumption into four categories, minor inaccura-
cies in alcohol intake are not likely to have a large
impact on our results. Some studies have argued
that the reference category of non-drinkers has an
increased risk for mortality, because this category
is a mixture of lifetime abstainers and former-
drinkers who because of illness ceased alcohol
drinking [17,18]. We did not have information on
Fig. 2. Cumulative incidence of diabetes in categories of
alcohol consumption.
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ex-drinkers. However, in studies in which ex-
drinkers were excluded from the category of non-
drinkers, the lifetime abstainers still had higher
mortality risk compared with moderate drinkers
[3,11,31]. Furthermore, in the multivariate analy-
ses we adjusted for prevalent cardiovascular
diseases.
Previous studies that showed that moderate
alcohol consumption was associated with a lower
mortality risk have been performed mainly in the
general population or in healthy subjects [1–4,31].
Three studies were performed among diabetic
subjects [11–13]. In the Wisconsin Epidemiologic
Study of Diabetic Retinopathy, the risk relative to
lifetime abstainers was lowest for subjects drink-
ing 14 g of alcohol a day (RR 0.21) [11]. In the
Physicians’ Health Study diabetic men who con-
sumed alcohol daily had a relative risk of 0.42 for
CHD mortality [12] and in the Nurses’ Health
Study the relative risk was 0.48 for those report-
ing usual intake (5 g per day) [13]. In should be
noted that all these studies were conducted in the
United States and that only a limited number of
subjects had higher intakes of alcohol. In the
Netherlands the range of alcohol consumption is
much broader. In the present study, both for
subjects with normal and for those with abnormal
glucose levels mortality risk increased with higher
intakes. The present study clearly indicates that in
the high-risk group of diabetes, IFG or IGT, the
absolute risk reduction with moderate alcohol
consumption was larger. However, with higher
alcohol consumption the risk increased faster
compared with subjects with normal glucose lev-
els, although the formal test on interaction did
not reach statistical significance.
At baseline, 71.5% of the subjects invited from
the general population participated in the Hoorn
Study. Of the 2086 subjects who were invited
for the follow-up examination, 1513 subjects
participated (72.5%). As is frequently observed
in population studies, the participants were
younger (60.6 vs. 63.2 years), had a lower waist-
to-hip ratio (0.89 vs. 0.90) and a more favourable
lipid profile at baseline. Their alcohol consump-
tion was 9.2 compared with 7.5 g per day of the
non-participants. The baseline glucose levels of
the participants were lower, which might have
underestimated the cumulative incidence of
diabetes.
The incidence of diabetes was lowest in the
category of 10 g alcohol a day. In a study
among middle aged British men, the lowest risk
for diabetes was seen in subjects who consumed
16–42 alcoholic drinks per week, corresponding
to about 23–60 g per day [16]. Wei et al. observed
the lowest risk with an alcohol intake between of
9–18 g per day, while higher intakes were associ-
ated with a twofold increase in risk [17]. However,
in the latter study the definition of diabetes was
based on fasting plasma glucose levels only.
As moderate alcohol consumption might be
associated with a healthy lifestyle, we adjusted for
the lifestyle variables smoking and physical activ-
ity. Nevertheless, this did not explain the observed
association. Biological mechanisms that might ex-
plain the associations between moderate alcohol
consumption, diabetes and mortality, might be
the increase in HDL-C and in fibrinolytic activity,
a decreased platelet aggregation and increased
insulin sensitivity [5–7,14,15]. The adverse effect
of high alcohol intake may be attributed to ele-
vated triglycerides level [5,14], hypertension, a
decreased insulin-mediated glucose uptake, liver
cirrhosis and a decreased glucose tolerance [14].
In the present study, the adverse cardiovascular
risk profile of subjects with abnormal glucose
levels might explain the fast increase in mortality
risk with higher alcohol consumption in these
subjects. Future research on this topic is needed
to further elucidate the mechanisms.
In conclusion, as moderate alcohol consump-
tion might lower mortality and diabetes risk,
moderate alcohol consumption should not be dis-
couraged. However, subjects should also clearly
be warned for the risks associated with over-
consumption.
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